
A cautious approach for now is warranted as well as a need for a randomized clinical trial.
Steven P. LaRosa, MD, is a board-certified physician in infectious disease. He is the Chief Medical Officer at Aethlon Medical, and a voluntary clinical professor in the Department of Medicine at the University of California, San Diego, Health Sciences.

A cautious approach for now is warranted as well as a need for a randomized clinical trial.

New review article outlines the evidence and future work that needs to be done with regards to doxycycline post-exposure prophylaxis (doxy-PEP).

Recent studies support the argument that all positive blood cultures trigger an automatic consultation.

Empirical antibiotic therapy in diabetic foot ulcer infections increases hospitalization and prolonged symptoms in patients being treated for lower limb cellulitis are common. Two recent papers examine the need for effective communication, the importance of objective findings in cellulitis management, and the benefits of culture-based antibiotic therapy in diabetic foot ulcer cases.

Association with Epstein-Barr virus reactivation sets the need for an antiviral clinical trial with cardiopulmonary exercise testing as an endpoint.

This new program from the federal agency can be viewed as a useful starting point for the development and assessment tool for sepsis programs with more granularity required.